Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Co. stock logo
ATPC
Agape ATP
$2.06
-7.6%
$1.69
$0.90
$8.00
$103.01M-0.551.76 million shs244,187 shs
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$3.28
+1.5%
$3.39
$2.18
$7.90
$35.30M0.7220,911 shs21,939 shs
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$23.88
+4.6%
$4.72
$0.65
$34.77
$143.81MN/A1.97 million shs10.22 million shs
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$1.75
-6.9%
$3.08
$1.70
$9.91
$65.93M0.99134,373 shs305,474 shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Co. stock logo
ATPC
Agape ATP
-7.62%+0.49%-13.08%+120.09%-59.94%
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-1.50%+15.09%+11.56%-54.41%-56.84%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
-4.25%+84.40%+1,241.57%+911.86%+2,387,999,900.00%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-6.91%-24.24%-48.83%-57.52%-78.66%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Co. stock logo
ATPC
Agape ATP
0.2895 of 5 stars
0.05.00.00.00.60.00.0
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
0.455 of 5 stars
0.03.00.00.00.61.70.6
Kindly MD, Inc. stock logo
KDLY
Kindly MD
1.0801 of 5 stars
0.05.00.00.02.61.70.0
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
0.641 of 5 stars
0.03.00.00.00.62.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Co. stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
0.00
N/AN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
0.00
N/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Co. stock logo
ATPC
Agape ATP
$1.29M79.66N/AN/A$1.14 per share1.81
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$515.82M0.07N/AN/A$10.56 per share0.31
Kindly MD, Inc. stock logo
KDLY
Kindly MD
$2.47M58.21N/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$115K573.28N/AN/A$2.21 per share0.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Co. stock logo
ATPC
Agape ATP
-$2.10M-$0.60N/AN/A-194.09%-74.71%-56.08%8/12/2025 (Estimated)
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-$92.07M-$1.88N/AN/A-83.50%-60.68%-42.30%5/26/2025 (Estimated)
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A-$0.77N/AN/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$36.24M-$0.94N/AN/AN/AN/A-51.73%-36.94%8/6/2025 (Estimated)

Latest BNR, ATPC, SERA, and KDLY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Agape ATP Co. stock logo
ATPC
Agape ATP
N/A-$0.07N/A-$0.07N/AN/A
5/14/2025Q1 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.24-$0.20+$0.04-$0.20$0.06 million$0.04 million
5/8/2025Q1 2025
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A-$0.17N/A-$0.17N/AN/A
3/31/2025Q4 2024
Agape ATP Co. stock logo
ATPC
Agape ATP
N/A-$0.20N/A-$0.20N/A$0.36 million
3/28/2025Q4 2024
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A-$0.17N/A-$0.17N/A$0.60 million
3/25/2025Q4 2024
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-$1.3970-$1.08+$0.3170-$1.08N/A$17.27 million
3/19/2025Q4 2024
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.23-$0.25-$0.02-$0.25$0.01 million$0.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Co. stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Co. stock logo
ATPC
Agape ATP
0.05
3.59
3.53
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/A
3.04
2.78
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A
5.43
5.42
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/A
2.11
2.11

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Co. stock logo
ATPC
Agape ATP
0.01%
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
30.03%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
54.64%

Insider Ownership

CompanyInsider Ownership
Agape ATP Co. stock logo
ATPC
Agape ATP
9.67%
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
30.30%
Kindly MD, Inc. stock logo
KDLY
Kindly MD
50.50%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
13.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Co. stock logo
ATPC
Agape ATP
4050.01 million3.60 millionNot Optionable
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
1,39010.76 million7.14 millionNot Optionable
Kindly MD, Inc. stock logo
KDLY
Kindly MD
N/A6.02 million2.96 millionN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
12037.67 million28.44 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$2.06 -0.17 (-7.62%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.06 +0.00 (+0.24%)
As of 05/23/2025 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$3.28 +0.05 (+1.55%)
Closing price 05/23/2025 03:52 PM Eastern
Extended Trading
$3.24 -0.04 (-1.22%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

Kindly MD stock logo

Kindly MD NASDAQ:KDLY

$23.88 +1.05 (+4.60%)
Closing price 05/22/2025 08:00 PM Eastern
Extended Trading
$23.88 0.00 (0.00%)
As of 05/22/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.

Sera Prognostics stock logo

Sera Prognostics NASDAQ:SERA

$1.75 -0.13 (-6.91%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$1.76 +0.01 (+0.86%)
As of 05/23/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.